Also, different subtypes also had their own specific variants, such as MET in adenocarcinoma, FGFR1 and FGFR3 in squamous cell carcinoma and MYC in small cell lung cancer (Zhang et al., 2017). This evidence concerns the gene MET and adenocarcinoma.